Marshall Wace »

Aeglea Biotherapeutics shares owned by Marshall Wace

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Marshall Wace from 13F filings

Historical chart of Marshall Wace investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Marshall Wace consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Marshall Wace

Quarter filed Position value Share count Share price at filing
2026-03-31 $7.0M 139k 50.44
2024-03-31 $6.1M 162k 37.93
2023-12-31 $436k 20k 21.52

More positions owned by Marshall Wace

Ishares-s&p 500 Etp (IVV)
Spdr Portfolio L Etp (SPYM)
Nvidia Corp Common Stock (NVDA)
Apple Common Stock (AAPL)
Amazon.com Common Stock (AMZN)
Microsoft Corp Common Stock (MSFT)
Adv Micro Device Equity Option Call Option (AMD)
Alphabet Inc-a Common Stock (GOOGL)
Chevron Corp Common Stock (CVX)
Taiwan Semic- Adr (TSM)
Broadcom Common Stock (AVGO)
Tesla Common Stock (TSLA)
Hilton Worldwide Common Stock (HLT)
Morgan Stanley Common Stock (MS)
Alphabet Inc-c Common Stock (GOOG)

View all positions for Marshall Wace

Top funds holding Aeglea Biotherapeutics

FMR
BlackRock
Rtw Investments
Fairmount Funds Management
Perceptive Advisors
VR Adviser
Vanguard Capital Management
Driehaus Capital Management
State Street Corporation
Paradigm Biocapital Advisors
Commodore Capital
TCG Crossover Management
Tang Capital Management
Wellington Management Company
Capital Research and Management Company - Division 3

View all funds holding Aeglea Biotherapeutics